Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Brian J. Boyarsky, William A. Werbel, Robin K. Avery, Aaron A.R. Tobian, Allan B. Massie, Dorry L. Segev, Jacqueline Garonzik‐Wang
Abstract
This study quantifies antispike protein antibody responses to first-dose messenger RNA (mRNA) COVID-19 vaccines in solid organ transplant recipients to better understand the immunogenicity of the vaccines in immunocompromised individuals.
Topics & Concepts
MedicineImmunogenicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologySolid organCoronavirus disease 2019 (COVID-19)Messenger RNA2019-20 coronavirus outbreakOrgan transplantationImmunologyTransplantationImmune systemInfectious disease (medical specialty)OutbreakInternal medicineGeneChemistryBiochemistryDiseaseSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyAnimal Virus Infections Studies